Page 893 - Read Online
P. 893

Cullen et al. Hepatoma Res 2020;6:76  I  http://dx.doi.org/10.20517/2394-5079.2020.69                                           Page 11 of 14
                                                                                [63]
               and the International Liver Transplantation, developed by Mazzaferro et al. . The tool is used to predict
               post-transplantation HCC specific survival, considering as events of interest only those deaths caused by
               tumor recurrence. The objective is to provide an upgraded prognostic tool and refine selection criteria
               for liver transplantation in patients with HCC. Outcome prediction was conducted using pre-operative
               determinants of prognosis frequently associated with higher risk of pre-transplantation tumor progression
               and poorer post-transplantation survival. The calculator is a free accessible tool found at www.hcc-olt-
                            [63]
               metroticket.org .
               CONCLUSION
               Until proven otherwise, surgical resection is the treatment of choice for patients with HCC confined to
               the liver. It has been shown that even patients with advanced HCC can achieve cure with a more radical
               resection as liver transplantation offers. Therefore, it is crucial that the transplant community changes the
               paradigm and improves transplant criteria for patients with HCC. We should focus more on tumor biology
               than size restrictions. In addition, tumor markers such as AFP and pathologic grade must be assessed.
               Response to pre-transplant locoregional therapies might be a surrogate marker of more favorable disease,
               which may impart lower post-transplant recurrence risk. In addition, current data proposes that PVTT
               should not necessarily be considered a contraindication.


               However, the question as to who should receive a liver transplant still persists. An important component
               to answering this question will be the transplant surgeons who continue to push the limits and boundaries
               by offering liver transplantation to advanced HCC patients. Nevertheless, the most crucial components
               to what can be achieved are the patients and the donors; their willingness to accept the risks will make it
               possible.


               DECLARATIONS
               Acknowledgments
               The authors acknowledge Andres Ramos for providing assistance with the illustrations in this manuscript.

               Authors’ contributions
               Participated in conception and design of the study; generation, collection, assembly, interpretation and
               critical revision of the data; drafting of the manuscript; approval of the final version of the manuscript:
               Cullen JM
               Participated in the generation, collection, assembly, interpretation and critical revision of the data; drafting
               of the manuscript; approval of the final version of the manuscript: Vargas P
               Participated in conception and design of the study; generation, collection, assembly, interpretation and
               critical revision of the data; drafting of the manuscript; critical revision of the manuscript for important
               intellectual content; approval of the final version of the manuscript: Goldaracena N


               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               None.

               Conflicts of interest
               All authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               Not applicable.
   888   889   890   891   892   893   894   895   896   897   898